MMP3, matrix metallopeptidase 3, 4314

N. diseases: 473; N. variants: 24
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group BEFREE The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. 10713697 2000
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 GeneticVariation group LHGDN A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. 12473595 2002
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 GeneticVariation group LHGDN The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. 15161710 2004
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 GeneticVariation group LHGDN Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion. 17922906 2007
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group CTD_human ERE-independent ERalpha target genes differentially expressed in human breast tumors. 16298037 2005
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 Biomarker group BEFREE MMP-1 (interstitial collagenase) has been associated with MDA-MB-231 invasion in vitro, while MMP-3 (stromelysin-1) has been localised around invasive cells of breast tumours in vivo. 16430785 2006
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 AlteredExpression group LHGDN Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model. 16158251 2005
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.370 AlteredExpression group LHGDN Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material. 17669621 2008